MENU
IVA
AS OF
Feb 3 closing price
Price
$6.19
Change
+$0.66 (+11.93%)
Capitalization
1.16B
56 days until earnings call
Intraday BUY SELL Signals
+Compare
IVA
Stock ticker: NASDAQ
AS OF
Feb 3 closing price
Price
$6.19
Change
+$0.66 (+11.93%)
Capitalization
1.16B

IVA Inventiva SA Forecast, Technical & Fundamental Analysis

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation... Show more

IVA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for IVA with price predictions
Feb 02, 2026

IVA sees MACD Histogram crosses below signal line

IVA saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on January 30, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 40 instances where the indicator turned negative. In of the 40 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for IVA moved out of overbought territory on January 29, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 26 similar instances where the indicator moved out of overbought territory. In of the 26 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on February 02, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IVA as a result. In of 93 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IVA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

IVA broke above its upper Bollinger Band on January 12, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

IVA moved above its 50-day moving average on December 26, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for IVA crossed bullishly above the 50-day moving average on December 31, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IVA advanced for three days, in of 236 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 148 cases where IVA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (27.778). P/E Ratio (0.000) is within average values for comparable stocks, (51.342). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.892). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (34.014) is also within normal values, averaging (333.006).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. IVA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IVA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
IVA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

IVA is expected to report earnings to rise 14.53% to -34 cents per share on April 01

Inventiva SA IVA Stock Earnings Reports
Q4'25
Est.
$-0.34
Q3'25
Missed
by $0.01
Q2'25
Missed
by $1.02
Q4'24
Missed
by $1.39
Q3'24
Missed
by $0.20
The last earnings report on November 21 showed earnings per share of -30 cents, missing the estimate of -28 cents. With 623.62K shares outstanding, the current market capitalization sits at 1.16B.
A.I. Advisor
published General Information

General Information

a company, which engages in the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis and related diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
50 rue de Dijon
Phone
+33 380447500
Employees
123
Web
https://www.inventivapharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IRFIX9.570.10
+1.06%
Cohen & Steers International Realty I
TEGCX17.050.06
+0.35%
Touchstone Sands Cptl Emerg Mkts Gr C
FREGX15.050.05
+0.33%
Nuveen Real Estate Securities R6
MWMIX32.57-0.52
-1.57%
VanEck Morningstar Wide Moat I
OPPAX84.78-2.38
-2.73%
Invesco Global A

IVA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, IVA has been loosely correlated with DRUG. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if IVA jumps, then DRUG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IVA
1D Price
Change %
IVA100%
-4.06%
DRUG - IVA
42%
Loosely correlated
+1.14%
TVGN - IVA
37%
Loosely correlated
-2.30%
OVID - IVA
30%
Poorly correlated
-3.21%
IVF - IVA
30%
Poorly correlated
-9.49%
NKTX - IVA
27%
Poorly correlated
-2.70%
More